Series D+-stage Healthcare AI investors
Healthcare AI investors writing series d+-stage checks. Cross-referenced with portfolio holdings, sub-vertical focus, and check-size range so you can shortlist credible leads for your raise.
Series D and subsequent funding rounds are highly advanced capital injections utilized by mature, pre-IPO companies. Startups raise these mega-rounds to finalize strategic acquisitions, weather unfavorable public market conditions, or achieve absolute global market dominance before executing a highly anticipated initial public offering or corporate sale.
63
investors match
Within Series D+: top healthcare sub-verticals
Roche Venture Fund
Corporate VC
T3
Biotech
Diagnostics
Samsung Catalyst Fund
Corporate VC
T3
AI/ML in Healthcare
Digital Health
Section 32
VC
T3
AI/ML in Healthcare
Biotech
Sequoia Capital
VC
T1
AI/ML in Healthcare
Biotech
Sixty Degree Capital
VC
T3
Biotech
Care Delivery / Tech-Enabled Services
Sofinnova Investments
VC
T3
Biotech
Pharma / Therapeutics
Sofinnova Partners
VC
T3
AI/ML in Healthcare
Biotech
Softbank Vision Fund
PE
AI
T3
AI/ML in Healthcare
Biotech
Spark Capital
VC
T3
AI/ML in Healthcare
Biotech
SR One
VC
T3
Biotech
Pharma / Therapeutics
Steadview Capital
PE
T2
Digital Health
Wellness / Consumer Health
Susquehanna Venture Capital
VC
T2
Health IT / Healthcare Software
SV Health Investors
VC
T3
Biotech
Care Delivery / Tech-Enabled Services
Temasek Holdings
PE
AI
T2
AI/ML in Healthcare
Biotech
Tiger Global Management
VC
T1
AI/ML in Healthcare
Care Delivery / Tech-Enabled Services